«ELISA-IgG-Sars-CoV‑2» reagent kit
«ELISA-IgG-Sars-CoV‑2» reagent kit created to detect immunoglobulins G by ELISA method. The Kit is confgured to analyze 46 unknown samples in negative control triplicate, positive control monoplicate. 96 defnitions in total.
PDF for download
Video instruction for using «ELISA-IgG-Sars-CoV‑2»
How to determine antibodies to the SARS-CoV-2 coronavirus (video)
In Vitro diagnostic ELISA based test kit for immunoglobulins G to SARS-Cov-2 in serum and plasma (EDTA, heparin, ACD or citrate).
Immunoglobulin G (IgG) represents approximately 75% of the human blood plasma antibodies. IgG is involved in infection control throughout the human body. It forms an important defense against a variety of pathogens: viruses, bacteria, fungi.
The IgG detection to SARS-Cov‑2 may assist to determine the immune response in patients with coronavirus disease, as well as to estimate the antibodies level in blood plasma in patients recovered.